pharma · Gastric Cancer · Colorectal Cancer
Ono Pharmaceutical
Ono Pharmaceutical Co.,
Ono Pharmaceutical Co is a pharma organization headquartered in CN. Primary therapeutic focus areas include Gastric Cancer, Colorectal Cancer, Metastatic Pancreatic Cancer, Chronic Sinusitis. NovaPharmaNews links 4 clini
Osaka, JP HQ
441 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Osaka, JP
- Employees
- 441
- Programs
- 4
- Drugs
- 2
- Patents
- 0
Nivolumab
Phase 3 · small molecule · Gastric Cancer
Nivolumab for Gastric Cancer is a Phase 3 program (small_molecule) at Ono Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Internal code ONO-4538-38
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Ono Pharmaceutical Co.,
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Gastric Cancer
- Status
- completed
- Trials
- 1